Sclerosing hepatic carcinoma: Helical CT features

被引:8
作者
Kim, Seong Hyun
Lee, Won Jae
Lim, Hyo K.
Park, Cheol Keun
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
来源
ABDOMINAL IMAGING | 2007年 / 32卷 / 06期
关键词
liver; neoplasm; CT; sclerosing hepatic carcinoma; hepatocellular carcinoma;
D O I
10.1007/s00261-006-9174-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The purpose of this study was to describe our experience, particularly for CT features, with four patients who had pathologically proven sclerosing hepatic carcinoma that mimicked other malignant hepatic tumors with abundant fibrosis at CT. Methods: Over a 10-year period, we collected four patients with surgically proven sclerosing hepatic carcinoma. All patients were men (age range, 49-63 years; mean, 56 years). Three-phase helical CT images were obtained in all patients, and their CT features were correlated with pathologic findings. Results: The tumor size ranged from 2.7 to 11 cm (mean, 7.2 cm). The tumors were manifested as a hypoattenuating mass with peripheral, rim enhancement at hepatic arterial phase, followed by centripetal enhancement progressively during portal venous and equilibrium phases. Histopathologically, the tumors showed features intermediate between hepatocellular carcinoma and cholangiocarcinoma with abundant fibrosis and surrounding liver had no liver cirrhosis. Conclusions: As described above, the CT features of sclerosing hepatic carcinoma may be similar to other malignant hepatic tumors with abundant fibrosis. Although sclerosing hepatic carcinoma is extremely rare, the radiologists should recognize that this tumor may be one of the malignant hepatic tumors with abundant fibrosis, especially in the non-cirrhotic liver.
引用
收藏
页码:725 / 729
页数:5
相关论文
共 13 条
[1]
Hepatic capsular retraction: spectrum of benign and malignant etiologies [J].
Blachar, A ;
Federle, MP ;
Brancatelli, G .
ABDOMINAL IMAGING, 2002, 27 (06) :690-699
[2]
HONG T, 2001, CHIN J RADIOL, V26, P147
[3]
Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype [J].
Kim, H ;
Park, C ;
Han, KH ;
Choi, JS ;
Kim, YB ;
Kim, JK ;
Park, YN .
JOURNAL OF HEPATOLOGY, 2004, 40 (02) :298-304
[4]
Sclerosing hepatic carcinoma in non-cirrhotic liver resembling metastatic adenocarcinoma [J].
Llovet, JM ;
Miquel, R .
JOURNAL OF HEPATOLOGY, 1999, 30 (01) :161-161
[5]
MACSWEEN RNM, 2002, PATHOLOGY LIVER, P711
[6]
Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium [J].
Maeda, A ;
Ebata, T ;
Matsunaga, K ;
Kanemoto, H ;
Bando, E ;
Yamaguchi, S ;
Furukawa, H ;
Uesaka, K .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2005, 12 (06) :484-487
[7]
'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1 [J].
Matsuura, S ;
Aishima, S ;
Taguchi, K ;
Asayama, Y ;
Terashi, T ;
Honda, H ;
Tsuneyoshi, M .
HISTOPATHOLOGY, 2005, 47 (04) :382-390
[8]
OMATA M, 1981, Liver, V1, P33
[9]
Park CI, 1994, KOREAN J PATHOL, V28, P636
[10]
Robrechts C, 1998, LIVER, V18, P288